Skip to main content
. 2012 Feb 20;1(1):16–26. doi: 10.1161/JAHA.111.000018

Figure 4.

Figure 4.

Cumulative percent reduction in odds of death at 24 months associated with sequential treatments compared with no treatment. Analysis includes only patients eligible for all 4 therapies (N=368). ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator.